THE USE OF BIOPROSTHETIC HEART VALVE IN A REPRODUCTIVE-AGED FEMALE PATIENT WITH ACQUIRED HEART DISEASE. SPECIFIC FEATURES OF DELIVERY
- Authors: RUTKOVSKAYA N.V1, ARTYMUK N.V2, STASEV A.N1, ODARENKO Y.N1, SAVOSTYANOVA Y.Y.1, SIZOVA I.N1, BARBARASH O.L1
-
Affiliations:
- Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
- Kemerovo State Medical Academy
- Issue: No 6 (2013)
- Pages: 65-69
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246956
- ID: 246956
Cite item
Abstract
Keywords
Full Text
About the authors
N. V RUTKOVSKAYA
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
Email: wenys@mail.ru
N. V ARTYMUK
Kemerovo State Medical Academy
Email: artymuk@gmail.com
Obstetrics and Gynecology Department Two
A. N STASEV
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
Email: astasev@gmail.com
Yu. N ODARENKO
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
Email: odarun2@mail.ru
Yu. Yu SAVOSTYANOVA
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
Email: ulisys@mail.ru
I. N SIZOVA
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
Email: swetlana.sap2@mail.ru
O. L BARBARASH
Research Institute of Complex Problems of Cardiovascular Diseases, Siberian Branch, Russian Academy of Medical Sciences
References
- Thiene G., Valente M. Anticalcification strategies to increase bioprosthetic valve durability. J. Heart Valve Dis. 2011; 20(1): 37-44.
- Tillquist M.N., Maddox T.M. Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement. Patient Prefer. Adherence. 2011; 5: 91-9.
- Butchart E.G. Antithrombotic management in patients with prosthetic valves: a comparison of American and European guidelines. Heart. 2009; 95(5): 430-6.
- Bloomfield P. Choice of heart valve prosthesis. Heart. 2002; 87(6): 583-9.
- Kulik A., Rubens F.D., Wells P.S., Kearon C., Mesana T.G., van Berkom J., Lam B.K. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann. Thorac. Surg. 2006; 81(2): 770-81.
- Otto C.M., Bonow R. O. Valvular heart disease a companion to Braunwald’s heart disease. Philadelphia: Saunders Elsevier; 2009.
- Pieper P.G., Balci A., Van Dijk A.P. Pregnancy in women with prosthetic heart valves. Neth. Heart J. 2008; 16(12): 406-11.
- Oakley R.E., Kleine P., Bach D.S. Choice of prosthetic heart valve in today’s practice. Circulation. 2008; 117(2): 253-6.
- DiSaila P. Pregnancy and delivery of a patient with Starr-Edwards mitral valve prosthesis: report of case. Obstet. Gynecol. 1966; 28: 469-72.
- Hall J.G. Embryopathy associated with oral anticoagulant therapy. Birth Defects Orig. Artic. Ser. 1976; 12(5): 33-7.
- Sillesen M., Hjortdal V., Vejlstrup N., S0rensen K. Pregnancy with prosthetic heart valves - 30 years’ nationwide experience in Denmark. Eur. J. Cardiothorac. Surg. 2011; 40(2): 448-54.
- Hung L., Rahimtoola S.H. Prosthetic heart valves and pregnancy. Circulation. 2003; 107(9): 1240-6.
- Ben Ismail M., Abid F., Trabelsi S., Taktak M., Fekih M. Cardiac valve prostheses, anticoagulation, and pregnancy. Br. Heart J. 1986; 55(1): 101-5.
- Salazar E., Izaguirre R., Verdejo J., Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J. Am. Coll. Cardiol. 1996; 27(7): 1698-703.
- Окли С., Уоренс К.А. Заболевания сердца у беременных: Пер. с англ. Поздняков Ю.М., Л.Е. Мурашко Л.Е., ред. М: БИНОМ; 2010. 368 c.
- Oakley C.M. Anticoagulants in pregnancy. Br. Heart J. 1995; 74(2): 107-11.
- Oakley C.M. Clinical and pregnancy perspectives: anticoagulation. Eur. Heart J. 1995; 16: 1317-9.
- Borger M.A., Ivanov J., Armstrong S., Christie-Hrybinsky D., Feindel C.M., David T.E. Twenty-year results of the Hancock II bioprosthesis. J. Heart Valve Dis. 2006; 15(1): 49-55; discussion: 55-6.
- Pibarot P., Dumesnil J.G. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009; 119(7): 1034-48.
- Караськов А.М., Назаров В.М., Железнев С.И. Дисфункции искусственных клапанов сердца. Новосибирск; 2008.
- Manji R.A., Zhu L.F., Nijjar N.K., Rayner D.C., Korbutt G.S., Churchill T.A. et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006; 114(4): 318-27.
- Барбараш Л.С., Барбараш О.Л., Журавлева И.Ю. Биопротезы клапанов сердца: проблемы и перспективы. Кемерово; 1995.
- Jamieson W.R., Burr L.H., Munro A.I., Miyagishima R.T. Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann. Thorac. Surg. 1998; 66(6,Suppl.1): S40-3.